Respiratory Syncytial Virus Infections
"Respiratory Syncytial Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
| Descriptor ID |
D018357
|
| MeSH Number(s) |
C02.782.580.600.620.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Infections".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Infections" by people in this website by year, and whether "Respiratory Syncytial Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 0 | 4 |
| 1997 | 2 | 0 | 2 |
| 1998 | 4 | 0 | 4 |
| 1999 | 6 | 1 | 7 |
| 2000 | 3 | 2 | 5 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 0 | 2 |
| 2003 | 7 | 1 | 8 |
| 2004 | 3 | 2 | 5 |
| 2005 | 4 | 1 | 5 |
| 2006 | 2 | 2 | 4 |
| 2007 | 6 | 1 | 7 |
| 2008 | 2 | 0 | 2 |
| 2009 | 5 | 0 | 5 |
| 2010 | 7 | 1 | 8 |
| 2011 | 5 | 0 | 5 |
| 2012 | 6 | 1 | 7 |
| 2013 | 5 | 1 | 6 |
| 2014 | 10 | 2 | 12 |
| 2015 | 10 | 2 | 12 |
| 2016 | 10 | 2 | 12 |
| 2017 | 9 | 2 | 11 |
| 2018 | 8 | 2 | 10 |
| 2019 | 7 | 3 | 10 |
| 2020 | 8 | 1 | 9 |
| 2021 | 12 | 0 | 12 |
| 2022 | 6 | 0 | 6 |
| 2023 | 13 | 0 | 13 |
| 2024 | 8 | 0 | 8 |
| 2025 | 16 | 0 | 16 |
| 2026 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus Infections" by people in Profiles.
-
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus. Clin Infect Dis. 2026 Mar 17; 82(3):e561-e570.
-
Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children. JAMA Pediatr. 2026 Mar 01; 180(3):314-324.
-
Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2?Years Hospitalized With RSV. Pediatrics. 2026 Feb 01; 157(2).
-
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein. Cell Rep Med. 2026 Feb 17; 7(2):102564.
-
Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus-Related Critical Illness. J Infect Dis. 2025 Dec 20; 232(6):1283-1291.
-
Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022-September 2023. Emerg Infect Dis. 2025 12; 31(14):20-29.
-
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation. Lancet Glob Health. 2025 Dec; 13(12):e2165-e2174.
-
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28; 334(16):1442-1451.
-
Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism. J Infect. 2025 Oct; 91(4):106617.
-
Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.